AcuraStem

AcuraStem is a patient-based biotechnology company developing treatments for neurodegenerative diseases like ALS and FTD. They utilize their iNeuroRx platform to model diseases in patient neurons, enabling the rapid discovery and testing of treatments, such as antisense oligonucleotides (ASOs). Their research focuses on targets like UNC13A and SYF2 to address TDP-43 pathology.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: $7M

Date: 30-Jan-2024

Investors: National Institutes of Health (NIH), Department of Defense (DOD)

Markets: Biotechnology, Healthtech, Neurodegenerative Diseases

HQ: Pasadena, California, United States

Founded: 2016

Website: https://acurastem.com/

LinkedIn: https://www.linkedin.com/company/12903559/

Twitter: https://twitter.com/acurastem

Instagram: